Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials

Published 2016 View Full Article

Authors

Keywords

Bendamustine, Rituximab, Chronic lymphocytic leukaemia, Therapy

Journal

EUROPEAN JOURNAL OF CANCER

Volume 60, Issue -, Pages 154-165

Publisher

Elsevier BV

Online

2016-04-29

DOI

10.1016/j.ejca.2016.03.069

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started